+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Narcolepsy Drugs Market by Drug Class (Amphetamine Salts, Modafinil Derivatives, Novel Agents), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Formulation, End User - Global Forecast 2025-2030- Product Image
Narcolepsy Drugs Market by Drug Class (Amphetamine Salts, Modafinil Derivatives, Novel Agents), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Formulation, End User - Global Forecast 2025-2030- Product Image
Sale

Narcolepsy Drugs Market by Drug Class (Amphetamine Salts, Modafinil Derivatives, Novel Agents), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Formulation, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674140
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The narcolepsy drugs market is undergoing significant transformation driven by ongoing therapeutic advancements, evolving regulatory landscapes, and the integration of digital technologies. Senior decision-makers navigating this segment must address complex challenges while seizing opportunities across patient populations and supply chains.

Market Snapshot: Narcolepsy Drugs Market Growth and Trajectory

The Narcolepsy Drugs Market grew from USD 3.28 billion in 2024 to USD 3.51 billion in 2025. It is expected to continue growing at a CAGR of 6.64%, reaching USD 4.83 billion by 2030. Market expansion is fueled by scientific developments in neurobiology, innovative drug classes, enhanced clinical trial pathways, and the increasing adoption of real-world data and digital health platforms. The competitive landscape blends established amphetamine-based therapies with novel agents that target wakefulness and disease modification, while regional differences in adoption, reimbursement, and research networks shape the global dynamic.

Scope & Segmentation of the Narcolepsy Drugs Market

This research report delivers a granular view enabling stakeholders to tailor strategies and optimize competitive positioning. The market is analyzed by the following comprehensive categories, with each segment influencing end-user adoption and market penetration:

  • Drug Class: Amphetamine salts, modafinil derivatives (including armodafinil and modafinil), novel agents (pitolisant and solriamfetol), and sodium oxybate.
  • Distribution Channel: Hospital pharmacies, online pharmacies, and retail pharmacy outlets.
  • Formulation: Capsules, solutions, and solid tablets supporting varied patient needs.
  • End User: Home use, hospitals, and specialized sleep clinics—each with distinct care delivery requirements.
  • Region: Americas (with breakdowns including the United States and key states such as California and Texas, plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major markets like the United Kingdom, Germany, France, Saudi Arabia, and South Africa), and Asia-Pacific (covering China, India, Japan, Australia, and Southeast Asian economies).
  • Company Coverage: Jazz Pharmaceuticals plc, Harmony Biosciences Holdings, Avadel Pharmaceuticals plc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Hikma Pharmaceuticals PLC, Sandoz Inc., Lupin Limited, Cipla Limited, Glenmark Pharmaceuticals Ltd.

Key Takeaways for Senior Decision-Makers

  • Innovative mechanisms of action are expanding the treatment landscape, with both traditional and next-generation therapies addressing previously unmet needs in narcolepsy.
  • Digital health adoption—including remote monitoring and patient engagement platforms—strengthens real-world outcomes measurement and supports adherence initiatives across care settings.
  • Shifts in regulatory policy, especially accelerated approvals and breakthrough designations, are shortening time-to-market for new therapies and increasing agility in response to patient needs.
  • Segmented patient populations and targeted formulations allow for customization of treatment and improved patient-centric approaches.
  • Strategic alliances, licensing agreements, and joint ventures between established pharmaceutical companies and biotech innovators drive research, development, and market access.
  • Expansion of patient assistance programs and pilot value-based contracts enhances affordability and supports long-term access, linking pricing to real-world therapeutic benefit.

Tariff Impact on Supply Chains and Market Access

U.S. tariffs imposed in 2025 on key pharmaceutical ingredients have resulted in heightened procurement complexity and increased manufacturing costs for narcolepsy drugs. Companies are responding with diversified sourcing, dual-supplier strategies, and greater investment in manufacturing process innovation. Partnerships with suppliers and increased inventory buffers help mitigate risk and promote continuity of access. These measures, supported by dialogue with trade groups and regulators, underscore the sector’s resilience amid global supply chain volatility.

Methodology & Data Sources

This report uses a multi-stage research methodology, combining structured interviews with industry professionals, comprehensive analysis of peer-reviewed literature, regulatory documents, and proprietary databases. Competitive assessments leverage SWOT and Porter’s Five Forces frameworks, with scenario analysis examining regulatory and supply chain factors for robust, validated insights.

Why This Report Matters

  • Enables strategic planning by providing actionable intelligence on evolving therapies, regulatory climates, and commercial opportunities in the narcolepsy drugs market.
  • Guides investment and portfolio decisions through in-depth segmentation, regional trends analysis, and innovation pipeline tracking.
  • Supports risk mitigation and growth forecasts, helping leaders anticipate disruptions such as tariff impacts and adapt operations for resilience and compliance.

Conclusion

The narcolepsy drugs market is defined by scientific progression, dynamic competition, and regulatory change. Leaders leveraging data-driven insights and strategic alliances are well positioned to capture emerging opportunities and advance patient care pathways in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of wake-promoting agent pipeline with novel mechanism of action trials exceeding traditional stimulants
5.2. Increasing FDA approvals and expanded indications for next-generation narcolepsy treatments improving patient outcomes
5.3. Rising adoption of personalized medicine in narcolepsy management leveraging genetic and biomarker profiling
5.4. Growth in patient-centric digital health solutions for narcolepsy symptom tracking and adherence support
5.5. Surge in strategic collaborations between biopharma and tech firms to develop AI-driven narcolepsy therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Narcolepsy Drugs Market, by Drug Class
8.1. Introduction
8.2. Amphetamine Salts
8.3. Modafinil Derivatives
8.3.1. Armodafinil
8.3.2. Modafinil
8.4. Novel Agents
8.4.1. Pitolisant
8.4.2. Solriamfetol
8.5. Sodium Oxybate
9. Narcolepsy Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Narcolepsy Drugs Market, by Formulation
10.1. Introduction
10.2. Capsules
10.3. Solution
10.4. Tablets
11. Narcolepsy Drugs Market, by End User
11.1. Introduction
11.2. Home Use
11.3. Hospitals
11.4. Sleep Clinics
12. Americas Narcolepsy Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Narcolepsy Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Narcolepsy Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Jazz Pharmaceuticals plc
15.3.2. Harmony Biosciences Holdings, Inc.
15.3.3. Avadel Pharmaceuticals plc
15.3.4. Teva Pharmaceutical Industries Ltd.
15.3.5. Viatris Inc.
15.3.6. Hikma Pharmaceuticals PLC
15.3.7. Sandoz Inc.
15.3.8. Lupin Limited
15.3.9. Cipla Limited
15.3.10. Glenmark Pharmaceuticals Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NARCOLEPSY DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NARCOLEPSY DRUGS MARKET: RESEARCHAI
FIGURE 24. NARCOLEPSY DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 25. NARCOLEPSY DRUGS MARKET: RESEARCHCONTACTS
FIGURE 26. NARCOLEPSY DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NARCOLEPSY DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY AMPHETAMINE SALTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY AMPHETAMINE SALTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY ARMODAFINIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY ARMODAFINIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY PITOLISANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY PITOLISANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SOLRIAMFETOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SOLRIAMFETOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOME USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOME USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SLEEP CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SLEEP CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 84. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 85. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 86. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 87. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 88. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 89. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 96. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 97. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 98. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 99. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 160. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 161. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 162. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 163. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 170. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 171. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 172. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 173. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 174. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 175. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 178. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 179. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 194. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 195. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 196. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 197. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 198. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 199. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 206. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 207. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 208. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 209. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 210. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 211. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 254. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 255. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 256. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 257. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 258. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 259. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 278. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 279. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 280. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 281. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 282. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 283. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 286. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 287. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 292. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 293. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 294. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 295. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 326. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 327. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 328. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 329. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 330. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 331. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 338. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 339. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 340. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 341. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2024 (USD MILLION)
TABLE 342. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2025-2030 (USD MILLION)
TABLE 343. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 346. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 347. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Narcolepsy Drugs market report include:
  • Jazz Pharmaceuticals plc
  • Harmony Biosciences Holdings, Inc.
  • Avadel Pharmaceuticals plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sandoz Inc.
  • Lupin Limited
  • Cipla Limited
  • Glenmark Pharmaceuticals Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.83 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033 - Product Image

Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Modafinil Oral Drugs Market by Product Type (Brand, Generic), Dosage Strength (100 Mg, 200 Mg), Application, Distribution Channel, End-User - Global Forecast 2025-2030 - Product Image

Modafinil Oral Drugs Market by Product Type (Brand, Generic), Dosage Strength (100 Mg, 200 Mg), Application, Distribution Channel, End-User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Narcolepsy Drugs Market Report and Forecast 2024-2032 - Product Image

Narcolepsy Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.